|
The FDA approved the experimental drug remdesivir for emergency use to treat COVID-19 recently, just days after a preliminary study reported it shortened hospital stays for COVID-19 patients.
In an emergency use authorization statement, the FDA's chief scientist, Denise Hinton, concluded, "It is reasonable to believe that the known and potential benefits of [remdesivir] outweigh the known and potential risks of the drug for the treatment of patients hospitalized with severe COVID-19."
|